![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
1. 1919868-77-1
2. Butanedioic Acid, 2-hydroxy-, (2r)-, Compd. With (2r)-(2r)-2-(2,5-difluorophenyl)pyrrolidine (1:1)
3. Mfcd31730920
4. (2r)-2-(2,5-difluorophenyl)pyrrolidine;(2r)-2-hydroxybutanedioic Acid
5. Schembl19614968
6. Amy12359
7. Ac8949
8. Ac-30673
9. (r)-2-(2,5-difluorophenyl)-pyrrolidin (r)2-hydroxysuccinate
Molecular Weight | 317.28 g/mol |
---|---|
Molecular Formula | C14H17F2NO5 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 4 |
Exact Mass | 317.10747897 g/mol |
Monoisotopic Mass | 317.10747897 g/mol |
Topological Polar Surface Area | 107 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 303 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Note: None of the products will be supplied to countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purposes only. However, the final responsibility lies with the buyer.